Fig. 5From: The TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement analysisComparison of quantitative enhancement (QE) maps for gadobutrol (a) and gadoteridol (b) reveals even very minor differences in contrast enhancement. In this case, the QE change map (c) shows that enhancement of the lesion rim (arrow) is slightly different between the agents. Purple indicates that enhancement is brighter after gadobutrol while yellow indicates that enhancement is brighter after gadoteridolBack to article page